Fractional CO2 Laser for Burn Scars
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how Fractional CO2 laser treatment can reduce pain and itch in hypertrophic burn scars, which are thick, raised scars that form after burns. Researchers aim to understand why this laser treatment helps by examining the scars closely over time. People with burn scars less than two years old, who experience pain or itch, and are already planning to have laser treatment might be good candidates. As an unphased trial, this study offers a unique opportunity for participants to contribute to understanding and improving treatments for burn scars.
Do I need to stop my current medications for the trial?
Yes, you will need to stop taking certain medications, especially those that interfere with wound healing, itch, or pain, such as steroids, antihistamines, opioids, and some others.
What prior data suggests that this laser treatment is safe for burn scars?
Research has shown that the Luminis Ultrapulse Fractional Ablative CO2 Laser is generally safe and effective for treating burn scars. One study found it thins scars and reduces symptoms, improving patients' quality of life. Another study confirmed its safety and effectiveness for large scars.
Overall, evidence suggests this laser treatment is well-tolerated, with few reports of serious side effects. The treatment uses laser energy to enhance the skin's appearance and texture, offering a promising option for those with thick burn scars seeking relief from pain and itchiness.12345Why are researchers excited about this trial?
Researchers are excited about the Luminis Ultrapulse Fractional Ablative Carbon Dioxide Laser for burn scars because it offers a precise, targeted approach to improving skin texture. Unlike traditional treatments like silicone gels or steroid injections that work on the surface or through medication, this laser penetrates deeper layers of the skin to stimulate collagen production. This not only helps in reducing the appearance of scars but might also improve skin elasticity and texture more effectively. Additionally, its fractional technology allows for quicker healing with minimal downtime, which is a significant advantage over more invasive procedures.
What evidence suggests that the Luminis Ultrapulse Fractional Ablative Carbon Dioxide Laser is effective for hypertrophic burn scars?
Research has shown that the Luminis Ultrapulse Fractional Ablative Carbon Dioxide Laser, which participants in this trial will receive, effectively improves thick burn scars. Studies have found that this laser treatment can reduce scar firmness by about 30% after just one session. It also enhances the appearance and texture of scars, making them less noticeable. Additionally, this treatment reduces scar thickness and improves the quality of life for individuals with these scars. Many patients experience less pain and itching, though the exact reasons remain unclear. Overall, the laser is considered a safe and effective option for treating burn scars.12467
Who Is on the Research Team?
Jonathan Friedstat, MD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for individuals with hypertrophic burn scars that are painful, itchy, or hypersensitive. Participants must have had the burn within the last two years and be planning to undergo laser treatment. They should agree to biopsies and a year of follow-up. Pregnant individuals or those on certain medications like steroids, antihistamines, pain relief drugs, or those affecting wound healing cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo standard treatment with fractional CO2 laser and additional skin biopsies, along with completing Patient Reported Outcome Measure questionnaires
Follow-up
Participants are monitored for histological changes and symptomatic improvement after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Luminis Ultrapulse Fractional Ablative Carbon Dioxide Laser
Luminis Ultrapulse Fractional Ablative Carbon Dioxide Laser is already approved in United States, European Union, Canada for the following indications:
- Hypertrophic Burn Scars
- Scar Reconstruction
- Burn Scar Management
- Burn Scar Treatment
- Scar Resurfacing
- Hypertrophic Scar Management
- Burn Scar Reconstruction
- Scar Treatment
- Hypertrophic Burn Scar Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor